Characterization of ex vivo cultured neuronal- and glial- like cells from human idiopathic epiretinal membranes by Andjelić, Sofija et al.
Andjelić et al. BMC Ophthalmology 2014, 14:165
http://www.biomedcentral.com/1471-2415/14/165RESEARCH ARTICLE Open AccessCharacterization of ex vivo cultured neuronal- and
glial- like cells from human idiopathic epiretinal
membranes
Sofija Andjelić1†, Xhevat Lumi1†, Xiaohe Yan2, Jochen Graw2, Morten C Moe3, Andrea Facskó4, Marko Hawlina1
and Goran Petrovski1,4,5*Abstract
Background: Characterization of the neuro-glial profile of cells growing out of human idiopathic epiretinal
membranes (iERMs) and testing their proliferative and pluripotent properties ex vivo is needed to better understand
the pathogenesis of their formation.
Methods: iERMs obtained during uneventful vitrectomies were cultivated ex vivo under adherent conditions and
assessed by standard morphological and immunocytochemical methods. The intracellular calcium dynamics of the
outgrowing cells was assessed by fluorescent dye Fura-2 in response to acetylcholine (ACh)- or mechano- stimulation.
Results: The cells from the iERMs formed sphere-like structures when cultured ex vivo. The diameter of the spheres
increased by 5% at day 6 and kept an increasing tendency over a month time. The outgrowing cells from the iERM
spheres had mainly glial- and some neuronal- like morphology. ACh- or mechano- stimulation of these cells
induced intracellular calcium propagation in both cell types; in the neuronal-like cells resembling action potential
from the soma to the dendrites. Immunocytochemistry confirmed presence of glial- and neuronal cell phenotype
(GFAP and Nestin-1 positivity, respectively) in the iERMs, as well as presence of pluripotency marker (Sox2).
Conclusion: iERMs contain cells of neuronal- and glial- like origin which have proliferative and pluripotent potential,
show functionality reflected through calcium dynamics upon ACh and mechano- stimulation, and a corresponding
molecular phenotype.
Keywords: Idiopathic epiretinal membrane, Glial- and neuronal cell growth, Pluripotency, Calcium dynamics,
Acetylcholine, Mechanostimulation, GFAP, Nestin-1, Sox2, Pax2Background
Epiretinal membranes (ERMs) are collections of cells
and extracellular matrix that occur on the vitreoretinal
interface of the central retina and are laid upon the
inner limiting membrane (ILM). They have contractile
properties and can lead to visual disturbance and meta-
morphopsia (distorted vision) due to their tractional ef-
fect on the underlying retina. The membranes comprise
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unless otherwise stated.macrophages, fibrocytes and collagen found in varying
proportions in accordance with their etiology. Idiopathic
epiretinal membranes (iERMs) occur without any associ-
ation with disease or disease history and are among the
most common types of ERMs [1]. Cells of glial origin pre-
dominate in the iERMs [2].
It is thought that the iERMs form initially as a result
of cell migration (RPE and glial cells such as Müller cells
and astrocytes) from within the retina. These cells can
either migrate through a hole or tear in the retina onto
its surface, as is generally assumed to be the case for
RPE cells, or they can simply extend processes out of
the retina, as is the case for glial cells [1,2]. Once the
scaffold for their growth has been formed or the existing
ILM has been populated by the migrating cells, otherl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hyalocytes - the cells of the vitreous body, and macro-
phages may come into the picture [3]. Cell contact and
attachment to the retina can cause proliferation and for-
mation of sheets of membranes over its surface [2].
Little is known about the presence of neuronal-like
cells and their function in human iERMs. Determining
the exact cell types found in the membranes has been
the focus of several previous studies [4-9]. Using light or
electron microscopy, it has been shown that many cells
seem to change their morphological characteristics as
the ERMs develop, making it difficult to identify their
origin [5-8]. In earlier studies [5,10,11], such cells were
identified as myofibroblasts, hyalocytes, fibrous astro-
cytes, RPE, and macrophages using only morphology as
the only means for identification. With the addition of
immunocytochemistry, however, it has become apparent
that the most abundant cell types found in the mem-
branes are glia, macrophages, RPE cells, and fibroblasts
[7,9,12,13].
Previously, no reports of ex vivo culturing of cells
coming out of iERMs and their functional and molecular
characterization have been described. Most of the pub-
lished studies present a microscopic observation of cells
found in the structure of ERMs. We postulate that trans-
differentiation of cells involved in the process of ERM
formation might be more frequent. We have taken iERM
material confirmed by clinical examination and optical
coherence tomography (OCT), and cultivated it under
adherent conditions. The proliferation potential and the
size of the outgrowing cells or spheres were followed
over a period of time. Although neuronal-like cells have
not yet been detected directly in ERMs, some evidence
exists for presence of Nestin-1 positive neural progenitor-
like cells in these membranes [14]. Those studies emphasize
the capacity of Müller cells, the predominant retinal glial
cells, to express Nestin-1 in response to different acute
damage such as experimental retinal detachment [15], and
hypothesize that Müller cells are able to re-differentiate
into retinal neurons after a neurodegenerative disease
[16]. Furthermore, the functionality of the iERM outgrow-
ing cells was hereby studied by assessing intracellular cal-
cium [Ca2+]i dynamics upon acetylcholine (ACh)- or
mechano- stimulation; such changes play an important
role in the regulation of cell function and affect every as-
pect of the cells’ life and death [17].
Methods
Ethics statement
All tissue collection complied with the guidelines of the
Helsinki Declaration and was approved by the National
Medical Ethics Committee of Slovenia. Patients’ ano-
nymity and informed consent were provided in each
case.Patient selection
A case-series study was performed on ten (10) patients
in which vitrectomy was carried out due to presence of
iERM as confirmed by OCT. The indication for surgery
was a decline of visual acuity (VA <0.5 on Snellen charts)
or better VA in cases when symptomatic metamorphopsia
affected the daily activities. Surgeries were performed
between May, 2012 and April, 2013 at the Eye Hospital,
University Medical Centre Ljubljana, Slovenia. Only pa-
tients with iERM were included, and those with secondary
or non-idiopathic ERM, as well as diabetic retinopathy,
glaucoma, corneal scars, patients after rhegmatogenous
retinal detachment, cataract and any other ocular condi-
tions affecting the VA were excluded. Assessment of the
VA, slit lamp biomicroscopy and fundus examination by
indirect ophthalmoscopy was performed in each patient
pre-operatively, and up to 6 month post-operatively.
The patient history included age, sex, side of the eye to
be operated (right or left eye). Using the Lens Opacities
Classification System III classification, patients classi-
fied as having nuclear opacities were excluded, if the
nuclear opalescence was grade ≥2.5.
Time-domain OCT imaging (3D OCT 1000 Topcon,
Japan) was performed in all cases and at each visit. Central
Foveal Thickness (CFT) and Total Macular Volume
(TMV) were recorded pre-operatively on the surgery
day, on the first post-operative day and 3 months post-
operatively.
Patients were examined post-operatively at day 1, 2 and
3, 1 week, 1 month and 6 months after the surgery.The
best corrected VA and intraocular pressure were mea-
sured at each visit.
Tissue collection and growth analysis
iERMs were removed en-block using endgripping for-
ceps. Immediately after removing, the excised tissue was
placed into sterile microtubes filled with (Balanced Salt
Solution +) BSS+. At the end of surgery, a 360o inspec-
tion of the peripheral retina was performed by scleral
depression and the vitreous cavity filled with BSS+. In
the case of any peripheral retinal break, an endolaser
retinopexy and air tamponade were performed. One part
of the iERMs was cultivated ex vivo under adherent con-
ditions in high glucose medium (DMEM , Sigma, No.
5671) supplemented with 10% fetal bovine serum (FBS).
The size and the shape of the outgrowing cells (area of
outgrowth) from the sphere-shaped iERMs were recorded
and followed on a daily basis up to 8 days and throughout
their continued growth for more than 3 months after the
isolation.
Immunohistochemical analysis of the iERMs
The remaining part from each isolated iERM underwent
immunohistochemical analysis. In brief, the surgically
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maldehyde for at least 24 hours. Then iERMs were
washed in PBS/0.1% TritonX-100 (PBST) two times, and
penetrated in 0.1 M Glycin/PBS. After washing in PBST,
iERMs were incubated in primary antibody (rabbit GFAP,
1:500, Cat.No.9269 (Sigma-Aldrich, Germany); mouse
Nestin, 1:500, Cat.No.561230 (BD Pharmingen, Germany);
rabbit Pax2, 1:200, Cat. No.2549-1 (Epitomics, Germany);
goat Sox2, 1:500, Cat.No.sc-17320 (Santa Cruz, Germany);
rabbit Ki-67, 1:1000, Cat.No.6013874 (Novocastra,
Germany); mouse CRALBP, 1:500, Cat.No.sc-376082
(Saanta Cruz, Germany)) or blocking solution (Control)
for 24 hours at 4°C, followed by washing and incubation
with secondary antibodies (rabbit Alexa Fluor ® 488, 1:250,
Cat.No.A21206 (Invitrogen, Germany); goat Cy3, 1:250,
Cat.No. 705-165-147 (Dianova, Germany); mouse Cy5,
1:250, Cat.No.715-175-150 (Jackson Immuno, Germany))
for 1 hour at room temperature. The samples were then
incubated in DAPI for 20 minutes and placed on the slides
with mounting medium. All the immunofluorescence
pictures (single plane images and Z-stacks) were taken
by Olympus confocal microscopy (Olympus, Hamburg,
Germany) and analyzed by a FluoView software (Olympus).
Below is a list of all antibodies used and their dilution.
Calcium dynamics measurement in iERM outgrowing cells
At day 8, the cultures were loaded with acetoxymethyl
(AM) ester of Fura-2 (Fura-2 AM; Invitrogen – Molecular
Probes, Carlsbad, CA, USA), a free cytosolic calcium (Ca2+)
sensitive dye which was dissolved in DMSO and suspended
in 1.5 mL of culture medium (final working concentration:
8 μΜ). The Fura-2 AM loading was carried out at 37 oC,
5% CO2 for 40 min. After loading, the cultures were
washed twice for 7 min with 3 mL of the physiological sa-
line with (in mM): NaCl (131.8), KCl (5), MgCl2 (2),
NaH2PO4 (0.5), NaHCO3 (2), CaCl2 (1.8), HEPES (10),
glucose (10)), pH 7.24. The Petri dish was then mounted
onto inverted microscope, Zeiss Axiovert S 100 (Carl
Zeiss, AG, Oberkochen, Germany). In order to evoke re-
sponses from the cells, an agonist - acetylcholine (ACh;
Sigma, USA) was applied in 25 μΜ concentration and di-
luted in physiological saline. The global application of
ACh as well as its washout from the bath was driven sim-
ply by the hydrostatic pressure of a 35 cm water column
and controlled manually by a Luer-lock stopcock (WPI)
and applied through a polyethylene plastic tubing (inner
diameter 2 mm) attached to the coarse micromanipulator.
The excess bathing solution was removed by a suction
line. To additionally test a response to mechanical stimuli,
such stimulation was carried out with a tip of a glass
micropipette mounted on a MP-285 micromanipulator
(Sutter, Novato, CA, USA) was used. Image acquisition
was done with the 12-bit cooled CCD camera SensiCam
(PCO Imaging AG, Kelheim, Germany). The softwareused for the acquisition was WinFluor (written by J.
Dempster, University of Strathclyde, Glasgow, UK).
Microscope objectives used were: 10x/ 0.30 Plan-
NeoFluar and 63x ⁄ 1.25 oil Plan-NeoFluar (Zeiss). The
light source used was XBO-75 W (Zeiss) Xe arc lamp.
The excitation filters used, mounted on a Lambda LS-
10 filter wheel (Sutter Instruments Co.) were 360 and
380 nm (Chroma). Excitation with the 360 nm filter
(close to the Fura-2 isosbestic point) allowed observa-
tion of the cells’ morphology and of the changes in the
concentration of the dye, irrespective of changes in
free cytosolic Ca2+ concentrations ([Ca2+]i), while the
360⁄380 nm ratio allowed visualization of the [Ca2+]i
changes in the cytoplasm. Image acquisition, timing and
filterwheel operation were all controlled by WinFluor soft-
ware via a PCI6229 interface card (National Instruments,
Austin, TX, USA). Individual image frames were acquired
every 500 ms resulting in frame cycles being 1 second long
(two wavelengths).
Statistical analyses
The statistical analysis used was paired Student’s t-test
(two tailed), which was conducted using SPSS software.
Results
Pre-operative and post-operative patient data
The iERMs were diagnosed clinically and by OCT in 10
patients (6 males and 4 females; age: 63 to 78 years
(average age: 72.2 ± 4.2 years)). Four eyes were phakic
and 6 were pseudophakic. Vitrectomy was performed in
the right eye in 5 and the left eye in 5 patients.
All patients had reduced VA (0.02 to 0.6 on Snellen
charts (mean VA: 0.31 ± 0.22)) and metamorphopsia pre-
operatively. In all cases, OCT clearly detected the ERMs
without any vitreoretinal traction. CFT was increased in
each of the patients and ranged from 371 μm to 649 μm
(mean thickness: 502.7 ± 81.15 μm). TMV ranged from
8.31 to 11.39 mm3 (mean value: 9.99 ± 1.10 mm3). The
surgery was in all cases 23-gauge sutureless vitrectomy.
There were no intra-operative or post-operative complica-
tions. In some of the patients, immediately after the ERM
removal, mild petechial haemorrhages occurred on the
retinal surface, which usually were not seen on the first
post-operative day. In one patient, at the end of the sur-
gery a peripheral retinal break was noticed for which laser
retinopexy and air tamponade were performed. During
the 6 months follow-up period the retina remained stable
in the later case.
Post-operatively the vision improved in 9 eyes, the VA
ranging from 0.1 to 0.7 (mean VA: 0.43 ± 0.23). One eye
(patient) had worse vision after surgery: the VA was re-
duced from 0.6 pre-operatively to 0.5 post-operatively.
The primary reason for the subsequent decrease in VA
was the occurrence or progression of nuclear sclerosis of
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duced in all patients and ranged from 273 to 432 μm
(mean: 336.2 ± 46.7 μm). The TMV decreased after sur-
gery and ranged from 7.64 to 8.77 mm3 (average value:
8.16 ± 3.46 mm3). These pre-operative and post-operative
differences were statistically significant (p < 0.05).
Growth potential of the iERM outgrowing cells
The cells from the iERMs formed sphere-like structures
when cultured ex vivo. The diameter of the spheres
increased significantly by 5% at day 6 (256.6 ± 90.0 μm,
p = 0.03) and kept an increasing tendency over a month
period. The cells growing out of the spheres had mainly
a glial or star-shaped morphology with many processes
coming out of the soma, while some had a neuronal-
like morphology with dendritic- and axonal- like exten-
sions coming out of the soma (Figure 1).
Immunophenotype of the cells found in the iERMs
The iERMs obtained from surgery were examined for
expression of glial-, neuronal- and pluripotency markers.
Most of the cells in the explanted iERMs expressed GFAP,
while some expressed Sox2 and Nestin-1 (Figure 2). Few
of the cells co-expressed GFAP and Sox (Figure 2, middle
panel images) and similarly, few of them co-expressed
GFAP, Sox2 and Nestin-1 at the same time (Figure 2,
lower panel images).
Only a trace amount of the cells expressed Ki-67
(Figure 3). Pax 2 (a developmental marker), was alsoFigure 1 Sphere-like growth of the cultivated iERMs. Data shown
are average of four independent experiments (*p = 0.03).detected in the iERMs, which was co-expressed with
some of the Sox2 and CRALBP (Müller glial marker)
positive cells, respectively (Figure 3).
Functionality of the iERM outgrowing cells
The functionality of the iERM outgrowing cells was
assessed by the [Ca2+]i dynamics upon ACh or mechanical
stimulation. Some cells derived from the iERM spheres
responded to the pharmacological stimulation by ACh
with an increase in [Ca2+]i, while others showed no change
in the [Ca2+]i. The rise in [Ca
2+]i was monophasic for the
activated cells (Figure 4A,B). The outgrowing cells from
the iERM spheres had mainly a glial- and some neuronal-
like morphology. Stimulation of these cells with ACh in-
duced [Ca2+]i changes in the neuronal-like cells, while
not in the glial-like cells (Figure 4A). Upon mechanical
stimulation of the single neuronal-like cells with glass
micropipette, [Ca2+]i propagation could be observed
from the cell body to the dendrites, resembling action
potential (Figure 4B).
The cell morphology, as assessed by observation of
360 nm fluorescencent images, is shown on Figure 4A
for the group of cells derived from the sphere of one pa-
tient, and for the single cells derived from the sphere of
another patient (Figure 4B). The regions of interest
(ROIs) are superimposed on the images of morphology,
and are presented in different colors which correspond
to the traces showing the time courses of the 360⁄380 ra-
tio, proportional to [Ca2+]i for the selected ROIs. The
resting levels, the increase in 360/380 ratio upon stimu-
lation and the amplitudes of the ratio of the responses,
corresponding to the resting levels and the changes in
[Ca2+]i can be seen in Figure 4.
Discussion
A case-series study of 10 patients with iERM is pre-
sented in which immunohistochemical and functional
evidence of their ex vivo proliferative and pluripotency
potential is shown. Apart from that, clinical data show-
ing similar postoperative outcomes of VA and OCT
changes to other previously published data are presented
in support of the successful procedures carried [18-20].
To date, the pathogenesis of ERMs is not fully clear.
The two main cellular components of the ERMs are cells
of retinal and extra-retinal origin, as well as extracellular
matrix (consisting of collagen, laminin, tenascin, fibro-
nectin, vitronectin and thrombospondin) [9,21]. The ori-
gin of the cells which contribute to ERM formation has
not been fully understood. Hiscot et al. identified oval
cells, spindle-shaped cells, and cuboidal cells in ERMs,
which stained positively for epithelial markers [4]. Fur-
ther histological and immunohistochemical analysis has
shown that cells involved in ERM formation are RPE
metaplastic cells, glial cells (Müller cells and astrocytes),
Figure 2 Immunofluorescent images of iERMs stained for GFAP, Sox2 and Nestin-1.
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monocytes, and macrophages [7,22]. Zhao et al. stated
that hyalocytes constitute a major cell type of the epiret-
inal cell proliferation in eyes with macular pucker and
vitreomacular traction syndrome. In the membranes,
they noticed myofibroblast-like cells, being immunoreac-
tive for α-SMA and of unknown origin, representingFigure 3 Immunofluorescent images of iERMs stained for Pax2, Sox2
as a marker for Müller glial cells of the retina).contractile elements of epiretinal tissue possibly as a
consequence of cellular transdifferentiation [23].
The only cellular components of the ERMs in a series
studied by Snead et al. were GFAP+ and AE1/AE3+ cells.
They preferred to name these cells laminocytes as a term
for glial cells, glial fibroblasts, astrocytic cells, and Muller
cells [24]. Lewis et al. found the proof of neurite growth inand Nestin-1. (Cellular retinaldehyde-binding protein (CRALBP) serves
Figure 4 Calcium dynamics in the neuronal-like cells derived from an iERM upon different stimulation. [Ca2+]i, responses upon acetylcholine
(ACh) (A) and mechano- stimulation (B).
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labelled processes [25].
Electron microscopy and immunocytochemical studies
have shown changes of the morphological characteristics
of cells during ERM development, but it was difficult to
distinguish the origin of these cells from morphological
studies only [6-8]. The outgrowth of Müller cell pro-
cesses onto the inner retinal surface has been considered
being the first step in the process of ERM formation
[10,26]. Schubert et al. suggested that under normal con-
ditions many vitreous fibers distribute tractional forces
to numerous Müller cell attachments. However, in cases
of partial posterior vitreous detachment (PVD), fewer
vitreous fibers and Müller cells endure most of the trac-
tion, which may result in a chronic irritation of Müller
cells. PVD and chronic irritation of Müller cells can facili-
tate a local release of factors that, in turn, can induce
Müller cell gliosis and vascular leakage [27]. General signs
of Müller cell gliosis are cellular hypertrophy and upregu-
lation of the intermediate filaments vimentin and GFAP,
followed by transient or long lasting proliferation of these
cells [12]. GFAP expression in simple ERMs demonstrates
that the majority of the cells involved in the membrane
formation derive from glial cells [13]. Within the mem-
branes, glial and pigment epithelial cells may transdiffer-
entiate to other cells, e.g. contractile myofibrocytes, which
is characterized by a reduction in cell-specific proteins
such as GFAP and cytokeratins [28,29].
In their immunocytochemistry model of ERMs,
Oberstein et al. showed the presence of Ki-67+ proliferating
glial-, ezrin+ RPE-, GFAP+ and vimentin+ glial cells, as well
as ricin+ immune cells in all four types of the ERMs
studied, regardless of their duration of occurrence in the
eye. According to their findings, there is strong evidencethat RPE cells can migrate through the intact retina [3].
These data support the hypothesis that ERM formation is
a wound healing process [30].
Bringmann et al. described how Müller cells in prolif-
erative vitreoretinopathy (PVR) can display a distinct po-
tential for transdifferentiation into a progenitor- or
neuron-like phenotype [31]. They hypothesized that cel-
lular transdifferentiation may represent one reason for
the relatively few glial and pigment epithelial cells being
detected in fibrocellular membranes by commonly used
immunocytochemical markers. Progenitor cells have been
found in tissues which have potential to regenerate and
differentiate into various phenotypes. One marker for pro-
genitor cells is Nestin. Mayer et al. found in adult human
retina and ERMs removed during retinal surgery Nestin-
staining patterns associated with cells of neural and glial
morphology. Nestin positive cells in the adult human ret-
ina display morphological and geographical similarity to
neurons, including retinal ganglion cells, other neurons,
and Müller cells. In the ERMs, these cells were found co-
expressed with GFAP [14].
In distinction to the histological and immunocyto-
chemical studies published so far, we established a differ-
ent model for analyzing the proliferative, differentiation,
pluripotency and functional potential of the cells isolated
from iERMs. The collected iERMs were cultivated ex vivo
under adherent conditions in high glucose medium sup-
plemented with 10% FBS. Cells from the ERM started to
form sphere like structures within first few days and kept
growing over a month period (the overall follow-up time
was 6 months when the ongoing growth was intentionally
discontinued). Within the first 6 days, the diameter of the
growing spheres increased significantly, the cells showing
mainly a glial or star-shaped morphology, while some
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reflected by most cells expressing GFAP, and some ex-
pressing Nestin-1. In addition, few cells expressed
Sox2, while some showed co-expression of Sox2 and
Nestin-1. Only a trace amount of the cells expressed
the cell proliferation marker Ki-67. Interestingly, Pax2
which is prominently expressed at sites where tissue
outgrowth and shaping takes place [32] was expressed
in the cells found in iERMs and it was found partially
co-expressed with Sox2 positive cells.
In animal models, it has been shown that small in-
creases in the levels of Sox2 expression (2-fold or less)
could lead to rapid differentiation of epithelial stem cells
into cells expressing neuroectodermal, mesodermal and
trophectodermal markers [33]. Sox2 is probably one of the
proteins which act as molecular rheostat in the control of
epithelial stem cell self-renewal and pluripotency [34].
Demonstrating the presence of Sox2 in the iERMs proved
the presence of pluripotency of at least some of the
cells growing out of the iERMs. These data are unique
in studying the proliferation of iERM cells altogether.
The neuronal-like cells in ERMs have not been found
directly, so neither has been their calcium signaling.
Nestin being an intermediate filament marker for neural
progenitor cells has been shown to exist in ERMs [14],
however, other studies have emphasized the capacity of
Müller cells, the predominant retinal glial cells, to ex-
press Nestin in response to different acute damage par-
adigms such as experimental retinal detachment [15].
These studies have hypothesized that Müller cells are
capable of re-differentiating into retinal neurons after a
neurodegenerative disease [16]. The calcium signaling
in outgrowing cells can be studied by chemical stimula-
tion following administration of ACh, and mechanical
stimulation, both being known to induce calcium sig-
naling in retinal cells [35]. ACh receptors are widely
present in the retina and they play important roles in it.
Nicotinic ACh receptors, alpha7 nAChR, are expressed
in RPE cells [36] and in bipolar, amacrine, and ganglion
cells of the rabbit retina [37]. Muscarinic receptors, M1
and M4 mAChR, are expressed in retinal ganglion cells
[38], and all five mAChR subtypes are expressed by
subpopulations of bipolar, amacrine, and ganglion cells
in the rabbit retina [39]. Amacrine cells, which are exci-
tatory cells with an ACh release early in the develop-
ment of the retina, have been show to require this
neurotransmitter for development of retinal waves [40].
The transient cholinergic network plays an important
role in the various aspects of retinal development [41].
Control of cell proliferation by neurotransmitters in the
developing vertebrate retina also involves ACh [42].
Neuroprotection of rat retinal ganglion cells against
glutamate-induced excitotoxicity is mediated through
alpha7 nACh receptors [43].The presence of ACh receptors on iERM cells and the
calcium response of these cells to ACh stimulation, to
the best of our knowledge, have not been studied before.
As iERMs appear to form initially as a result of cells
coming from within the retina, and since ACh plays an
important role in retinal development, altogether, this
suggests a putative role of ACh in the iERM develop-
ment, which we studied further. Nicotinic ACh receptors
have multiple roles in proliferation in cancer in general
[44], suggesting they might have a similar role in the pro-
liferation of iERM cells. Recent studies have documented
the effect of topical nicotine on improving dermal wounds
[45] suggesting it may have roles in wound repair, there-
fore, possibly cell repair as well. Blocking n- and m-
AChRs on non-innervated cells causes cellular dysfunction
and/or cell death. Embryonic stem cells from mice, epithe-
lial, endothelial and immune cells can all synthesize ACh,
which via differently expressed patterns of n- and
mAChRs can modulate cell activities to respond to in-
ternal or external stimuli. This helps maintain and
optimize cell function, such as proliferation, differenti-
ation, formation of a physical barrier, migration, and
ion and water movements [46].
Alternatively, when cells are stimulated by mechanical
deformation, in particular, when diseases characterized
by mechanical stress cause stretching of the RPE cells by
the vitreous or hyperplastic membranes' formation as in
rhegmatogenous retinal detachment and PVR, the ‘on’
mechanisms become activated and the cytosolic free Ca2+
concentration increases. The Ca2+ ‘on’ mechanisms can
include channels located at the plasma membrane which
can further regulate the inexhaustible supply of Ca2+ from
the extracellular space, and channels on the endoplasmic
and sarcoplasmic reticulum which release the finite intra-
cellular Ca2+ stores [47]. Mechanical stimulation of iERM
cells has not been described so far, although mechanical
stimulation of retinal cells has shown changes in the [Ca2+]i
levels. Mechanical stimulation of astrocytes of rat retina
could initiate an increase in the [Ca2+]i that propagated
through astrocytes and Müller cells as intercellular waves.
Generation of Ca2+ waves can occur by the release of Ca2+
from internal stores, but the waves do not evoke changes in
cell membrane potential. It was suggested that such glial
Ca2+ waves may constitute an extraneuronal signaling path-
way [48,49]. Forces applied to resting primary astrocytes
produced a fast transient change of [Ca2+]i adapting within
seconds [50]. Furthermore, stimulation of RPE cells with
mechanical stress can upregulate matrix metalloproteinases
(MMP-2) and fibronectin (FN) expression through activa-
tion of the p38 pathway [51].
Elevated intraocular pressure can also trigger a physio-
logical release of ATP from the retina. Stimulation of the
purinergic P2X7 receptor for ATP on retinal ganglion cells
can lead to elevation of [Ca2+]i and excitotoxic death
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to mechanical deformation with pannexin-mediated
ATP release and autostimulation of P2X7 receptors [53].
Since calcium signaling can occur in both neuronal
and glial cells, calcium imaging cannot be used for dis-
criminating glia cells from neurons [54-56], which can
be an obvious limitation of this study. Glial cells can re-
spond to various stimuli with an increase in [Ca2+]i, but
not by forming action potentials. Mechanical stimulation
of astrocyte somata in rat retina could evoke calcium
waves that could propagate through both astrocytes and
Müller cells [49]. Calcium signaling upon ACh stimula-
tion has been demonstrated in cultured retinal neurons
and Müller cells [57]. Forces applied to resting primary
astrocytes produce a fast transient change of [Ca2+]i
adapting within seconds [50]. ACh receptors are known
to exist in astrocytes of rat hippocampus and cortex
[58,59] and to induce the increase in [Ca2+]i.
Overall, the etiology, cellular types and the origin of
the cells found in ERMs has been a matter of long-term
debate. Investigations searching for cell type–specific
markers expressed on ERM cells, in particular coming
from iERMs, have not lead to a distinct conclusion
about their origin, probably due to phenotypic transdiffer-
entiation and lack of a specific marker for transdifferen-
tiated cells thereof [7]. A majority of the present cells in
this study were GFAP+, however some Sox2+ and Ki-67+
cells, as well as Pax2+ (a putative new marker for cells
found in iERMs) could be detected in the studied mem-
branes. Therefore, we postulate that cells found in iERMs
have a proliferative and differentiation or transdifferentia-
tion potential [23] based upon their immunocytochemical
properties and growth patterns, and the functional studies
with chemo- and mechano- stimulation. Further func-
tional studies as well as protein and gene expression
studies are needed to find out which ACh receptor types
in iERMs are affected by application of different ago-
nists and antagonists, and which one of them can fur-
ther affect the proliferation and differentiation potential
of the ERM cells.
Conclusions
Outgrowing cells from human iERMs show mainly glial-
and some neuronal- like phenotype (GFAP and Nestin-1
positivity, respectively), proliferate and express pluripotency
potential (Sox2 positivity). ACh- or mechano- stimulation
of these cells induces intracellular calcium propagation; in
the neuronal-like cells, it resembles action potential from
the soma to the dendrites.
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